Barzan L, Sulfaro S, Alberti F, Politi D, Pin M, Savignano M G, Marus W, Zarcone O, Spaziante R
Otorhinolaryngology Unit, S. Maria degli Angeli Hospital, Pordenone, Italy.
Acta Otorhinolaryngol Ital. 2004 Jun;24(3):145-9.
Most studies concerning the use of the sentinel node technique in head and neck cancers have included clinically N0 patients with primary early stage tumours of the oral cavity or upper part of oropharynx; furthermore, node sampling has been performed during the same session, but separately from the tumour. The perspective of avoiding unnecessary neck dissection, without increasing the risk of delayed diagnosis of lymph node metastasis, is rewarding, not only for early stage tumours of the oral cavity but also for tumours in advanced stages and/or at different anatomic sites. In the attempt to establish the reliability of extended use of the sentinel node technique, 100 consecutive untreated patients (from 1999 to 2002) with tumours located in the oral cavity, oropharynx, hypopharynx and larynx, at any T stage, entered the study. N+ patients with paramedian tumours and contralateral clinically negative nodes were also enrolled. After injection of the 99mTc albumin microcolloid, pre- and intra-operative evaluations with a gamma-probe were done. N0 patients (59) were submitted to mono- or bilateral selective neck dissection; the N+ patients (41) received homolateral dissection of all levels and contralateral selective dissection. An en bloc resection of the tumour was performed both in N0 and N+ patients. In the N0 group, histological examination showed no evidence of metastases in "hot" nodes in 34 patients and also the remaining nodes were negative. Metastases were found in one or more of the gamma-probe positive nodes (14 cases), or in a closely located node at the same level (2 cases) or in a node close to a "hot" area of the submandibular salivary gland (1 case). In 8 patients, lymphoscintigraphy did not identify any sentinel node and histology of all lymph nodes was negative for metastases. In the N+ group, no metastases were found in the sentinel nodes of 21 patients and also the remaining nodes were negative; in 4 patients, metastases were found in sentinel nodes. In 16 patients, lymphoscintigraphy did not identify any sentinel node and histology of all lymph nodes was negative for metastases. In no patients were metastases found outside the level containing the lymph node identified as sentinel by the gamma-probe. In conclusion, the strategy of the sentinel node is reliable, but, to be confirmed as a standard approach, it requires trials with a larger number of patients. The technique requires a multidisciplinary and well "amalgamated" team. It may likely be used also in T3 and T4 oro-hypopharyngeal and laryngeal primary tumours and to determine surgical treatment of the contralateral neck in patients with N2a, N2b, N3 on T close to the midline.
大多数关于前哨淋巴结技术在头颈癌中应用的研究纳入了临床上N0期的患者,其原发肿瘤为口腔或口咽上部的早期肿瘤;此外,淋巴结采样在同一次手术中进行,但与肿瘤切除分开。避免不必要的颈部清扫,同时不增加淋巴结转移延迟诊断风险的前景是值得期待的,这不仅适用于口腔早期肿瘤,也适用于晚期肿瘤和/或不同解剖部位的肿瘤。为了确定前哨淋巴结技术广泛应用的可靠性,100例连续未经治疗的患者(1999年至2002年)进入研究,这些患者的肿瘤位于口腔、口咽、下咽和喉部,处于任何T分期。N+期且肿瘤位于中线旁及对侧临床阴性淋巴结的患者也被纳入。注射99mTc白蛋白微胶体后,使用γ探测器进行术前和术中评估。N0期患者(59例)接受单侧或双侧选择性颈部清扫;N+期患者(41例)接受同侧各级淋巴结清扫及对侧选择性清扫。N0期和N+期患者均进行肿瘤整块切除。在N0组中,组织学检查显示34例患者的“热”淋巴结无转移证据,其余淋巴结也为阴性。在14例患者中,在一个或多个γ探测器阳性淋巴结中发现转移,或在同一水平紧邻的淋巴结中发现转移(2例),或在靠近下颌下唾液腺“热”区的淋巴结中发现转移(1例)。8例患者的淋巴闪烁显像未发现任何前哨淋巴结,所有淋巴结组织学检查均无转移。在N+组中,21例患者的前哨淋巴结未发现转移,其余淋巴结也为阴性;4例患者的前哨淋巴结发现转移。16例患者的淋巴闪烁显像未发现任何前哨淋巴结,所有淋巴结组织学检查均无转移。在任何患者中,均未在γ探测器确定为前哨淋巴结所在水平以外发现转移。总之,前哨淋巴结策略是可靠的,但要被确认为标准方法,需要更多患者参与的试验。该技术需要一个多学科且融合良好的团队。它可能也可用于T3和T4期口咽、下咽和喉部原发性肿瘤,以及确定T靠近中线、N2a、N2b、N3期患者对侧颈部的手术治疗。